Business Overview

We primarily engage in researching, developing, manufacturing and selling bamboo charcoal biomass organic fertilizers, amino acid water-soluble fertilizers, selenium-rich foliage fertilizers and other types of fertilizers in the PRC through our subsidiary, Jiangxi Kenongwo Technology Co., Ltd. ("Jiangxi Kenongwo"), a company incorporated under the laws of the PRC.





We generated our revenue from the sales of our organic fertilizers. We currently
have one integrated factory covering a land area of 143,590 square feet in
Yichun City, Jiangxi Province, PRC to produce our organic fertilizers, which has
been in operations since 2017. We plan to expand our production capacity and
build an automatic and standardized production line.



We believe that our brand reputation and ability to tailor our products to meet
the requirements of various regions of the PRC affords us a competitive
advantage. We purchase the majority of our raw materials from suppliers located
in the PRC and use suppliers that are located in close proximity to our
manufacturing facilities, which helps us to control our cost of revenue.



Amidst the COVID-19 outbreak in 2020, our business operations were adversely
impacted. In particular, the lockdown policy in China has caused delays in the
logistics industry and consequently, the supply of our raw materials were
impacted. In addition, the restrictions of face-to-face interactions have slowed
down the process of our marketing, client meeting and new products launching
activities. The spread of COVID-19 has been effectively controlled in China.
People's daily life and businesses' operations started going to normalcy. As a
result, we believe these negative impacts are temporary. However, there is
significant uncertainty around the breadth and duration of business disruptions
related to COVID-19, as well as its impact on the economy of China and the rest
of the world and, as such, the extent of the business disruption and the related
financial impact cannot be reasonably estimated at this time.



China is the principal market for our products, which are primarily sold to our
customers through distributors in over twenty provinces in China, including
Beijing, Henan, Hebei, Jiangxi, Hunan, Hubei, Fujian, Jiangsu, Shanghai,
Zhejiang, Sichuan, Chongqing, Guangdong, Hainan, Xinjiang, Guizhou, Anhui,
Shandong, Shanxi, Shaanxi, Liaoning, Jilin, Heilongjiang, Yunnan and Guangxi
provinces.



Critical Accounting Policies



Management's discussion and analysis of our financial condition and results of
operations are based upon our consolidated financial statements, which have been
prepared in accordance with US GAAP. Our financial statements reflect the
selection and application of accounting policies that require management to make
significant estimates and judgments. We believe the following critical
accounting policies used in the preparation of our financial statements require
significant judgments and estimates. For additional information relating to
these and other accounting policies, see Note 2 to our financial statements
included elsewhere in this report.



Basis of Presentation


Our financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP.





Going Concern



The accompanying unaudited condensed consolidated financial statements have been
prepared assuming that the Company will continue as a going concern; however,
the Company has incurred a net loss of $657,863 for the nine months ended
September 30, 2021. As of September 30, 2021, the Company had an accumulated
deficit of $1,693,412, working capital deficit of $2,149,691; its net cash used
in operating activities for the nine months ended September 30, 2021 was
$764,741.



The Company plans to continue its expansion and investments, which will require continued improvements in revenue, net income, and cash flows.





Revenue Recognition



The Company adopted ASC 606 "Revenue Recognition", and recognizes revenue when
control of the promised goods or services is transferred to customers, in an
amount that reflects the consideration we expect to be entitled to in exchange
for those goods or services.



The Company derives its revenues from the sale of fertilizer products. The
Company applies the following five steps in order to determine the appropriate
amount of revenue to be recognized as it fulfils its obligations under each of
its agreements:



  ? identify the contract with a customer;

  ? identify the performance obligations in the contract;




                                      16





  ? determine the transaction price;

? allocate the transaction price to performance obligations in the contract; and



  ? recognize revenue as the performance obligation is satisfied.




Results of Operations



Comparison of the Three months ended September 30, 2021 and 2020





                                             For the Three months ended
                                                    September 30,                      Variance
                                                2021               2020          Amount           %
                                                 $                  $              $
Revenues                                           69,565           34,632         34,933         100.9 %
Cost of revenues                                   54,022           44,238          9,784          22.1 %
Gross profit                                       15,543           (9,606 )       25,149         261.8 %
Operating expenses:
Selling expenses                                   86,592           82,736          3,856           4.7 %

General and administrative expenses               139,884          313,779       (173,895 )       (55.4 )%
Total operating expenses                          226,476          396,515       (170,039 )       (42.9 )%
Loss from operations                             (210,933 )       (406,121 )      195,188         (48.1 )%
Other income (expense):
Interest expense                                   (8,292 )         (1,104 )       (7,188 )       651.1 %
Other income (expense), net                        (2,458 )        (27,353 )       24,895         (91.0 )%
Total other (expense) income                      (10,750 )        (28,457 )       17,707         (62.2 )%
Loss before income taxes                         (221,683 )       (434,578

)      212,895         (49.0 )%
Income taxes                                            -            2,299         (2,299 )      (100.0 )%
Net loss                                         (221,683 )       (432,279 )      210,596         (48.7 )%




Revenue



For the three months ended September 30, 2021, our total revenue was $69,565,
representing an increase of 100.9% compared to $34,632 for the same period in
2020. This increase was mainly due to an increase in demand of our products.



The Company's disaggregate revenue streams are summarized as follows:





                                           For the Three months ended
                                                  September 30,
                                            2021                2020

Revenues - Solid organic fertilizers $ 35,404 $ 22,329 Revenues - Liquid organic fertilizers 34,161

              12,303
Total revenues                          $      69,565       $      34,632




Cost of revenues


Cost of revenues for the fertilizers was $54,022 and $44,238 for the three months ended September 30, 2021 and 2020, respectively, representing an increase of 22.1%. The increase in cost of revenues was in line with an increase in revenue.





The Company's disaggregate cost of revenues streams are summarized as follows:



                                                   For the Three months ended
                                                          September 30,
                                                    2020                2020

Cost of revenues - Solid organic fertilizers $ 25,818 $ 42,320 Cost of revenues - Liquid organic fertilizers 28,204


1,918
Total cost of revenues                          $      54,022       $      44,238




                                      17





Gross Profit



Our gross profit was $15,543 and negative $9,606 with gross margin of 22.3% and
negative 27.7%, for the three months ended September 30, 2021 and 2020,
respectively. The increase in gross margin because the revenue increased 100.9%
while the cost of revenue increased 22.1% for the three months ended September
30, 2021 compared to the same period in 2020.



Selling Expenses



Our selling expenses were $86,592 for the three months ended September 30, 2021,
representing an increase of $3,856 or 4.7% compared to $82,736 for the three
months ended September 30, 2020. The increase in our selling expenses was mainly
due to the fact that we incurred more costs in promotion and transportation cost
compared with 2020. The increase in our selling expenses is also in line with
the increase in revenue.


General and Administrative Expenses





General and administrative expenses decreased by $173,895, or 55.4% from
$313,779 for the three months ended September 30, 2020 to $139,884 for the same
period in 2021 due to the fact that we incurred more professional fee in third
quarter of 2020 compared with the third quarter of 2021.



Research and Development ("R&D") Expenses





Research and development expenses include salaries and other
compensation-related expenses paid to the Company's research and product
development personnel while they are working on R&D projects, as well as raw
materials used for the R&D projects. R&D expenses incurred by the Company are
included in the general and administrative expenses and totaled $42,538 and
$11,728 for the three months ended September30, 2021 and 2020, respectively.



Net Loss



Our net loss was $221,683 and $432,279 for the three months ended September 30,
2021 and 2020, respectively, representing a decrease of $210,596. The Company is
at its developing stage and we incurred more promotion fee by introducing our
products to more customers across China during the third quarter of 2020. The
Company also incurred more material cost by developing more new product lines
during the third quarter of 2020. The Company expects that more time is needed
to achieve a better balance between our operating expenses and revenues.



Comparison of the Nine months ended September 30, 2021 and 2020





                                             For the Nine months ended
                                                   September 30,                      Variance
                                               2021               2020          Amount           %
                                                 $                 $              $
Revenues                                         349,259          207,965        141,294          67.9 %
Cost of revenues                                 517,826          234,249        283,577         121.1 %
Gross profit                                    (168,567 )        (26,284 )     (142,283 )       541.3 %
Operating expenses:
Selling expenses                                 215,984          161,099         54,885          34.1 %

General and administrative expenses              263,670          515,402  

    (251,732 )       (48.8 )%
Total operating expenses                         479,654          676,501       (196,847 )       (29.1 )%
Loss from operations                            (648,221 )       (702,785 )       54,564          (7.8 )%
Other income (expense):
Interest expense                                 (21,406 )         (2,668 )      (18,738 )       702.3 %
Other income, net                                 11,764           24,960        (13,196 )       (52.9 )%
Total other (expense) income                      (9,642 )         22,292        (31,934 )      (143.3 )%
Loss before income taxes                        (657,863 )       (680,493 )       22,630          (3.3 )%
Income taxes                                           -            2,299         (2,299 )      (100.0 )%
Net loss                                        (657,863 )       (678,194 )       20,331          (3.0 )%




                                      18





Revenue



For the nine months ended September 30, 2021, our total revenue was $349,259,
representing an increase of 67.9% compared to $207,965 for the same period in
2020. This increase was mainly due to an increase in demand of our products.



The Company's disaggregate revenue streams are summarized as follows:





                                          For the Nine months ended
                                                September 30,
                                            2021               2020

Revenues - Solid organic fertilizers $ 278,250 $ 179,563 Revenues - Liquid organic fertilizers 71,008

           28,402
Total revenues                          $     349,259       $  207,965




Cost of revenues



Cost of revenues for the fertilizers was $517,826 and $234,2491 for the nine
months ended September 30, 2021 and 2020, respectively, representing an increase
of 121.1%. The increase in cost of revenues was in line with an increase in
revenue.



The Company's disaggregate cost of revenues streams are summarized as follows:



                                                  For the Nine months ended
                                                        September 30,
                                                    2021               2020
Cost of revenues - Solid organic fertilizers    $     415,749       $  212,125
Cost of revenues - Liquid organic fertilizers         102,077           22,124
Total cost of revenues                          $     517,826       $  234,249




Gross Profit



Our gross profit was negative $168,567 and negative $26,284 with gross margin of
negative 48.3% and negative 12.6%, for the nine months ended September 30, 2021
and 2020, respectively. The negative gross margin increased because the revenue
increased only 67.9% while the cost of revenue increased 121.1% for the nine
months ended September 30, 2021 compared to the same period in 2020.



                                      19





Selling Expenses



Our selling expenses were $215,984 for the nine months ended September 30, 2021,
representing an increase of $54,885 or 34.1% compared to $161,099 for the nine
months ended September 30, 2020. The increase in our selling expenses was mainly
due to the fact that we incurred more costs in promotion and transportation cost
compared with 2020. The increase in our selling expenses is also in line with
the increase in revenue.


General and Administrative Expenses





General and administrative expenses decreased by $251,732, or 48.8% from
$515,402 for the nine months ended September 30, 2020 to $263,670 for the same
period in 2021 due to the fact that we incurred more professional fee in first
three quarters of 2020 compared with the first three quarters of 2021.



Research and Development ("R&D") Expenses





Research and development expenses include salaries and other
compensation-related expenses paid to the Company's research and product
development personnel while they are working on R&D projects, as well as raw
materials used for the R&D projects. R&D expenses incurred by the Company are
included in the general and administrative expenses and totaled $52,856 and
$52,838 for the nine months ended September 30, 2021 and 2020, respectively.



Net Loss



Our net loss was $657,863 and $678,194 for the nine months ended September 30,
2021 and 2020, respectively, representing a decrease of $20,331. The Company is
at its developing stage and we incurred more promotion fee and hired more
employees by introducing our products to more customers across China during the
first third quarter of 2020. The Company expects that more time is needed to
achieve a better balance between our operating expenses and revenues.



Liquidity and Capital Resources

Our working capital deficit was $2,149,691 and $1,485,784 for the nine months ended September 30, 2021 and as of December 31, 2020, respectively.

We have respectively financed our operations over the nine months ended September 30, 2021 and 2020 primarily through proceeds from advances from related parties.

The components of cash flows are discussed below:





                                              For the Nine months ended
                                                    September 30,
                                                 2021             2020

Net cash used in operating activities $ (764,741 ) $ (818,517 ) Net cash used in investing activities

             (463,008 )      (336,248 )
Net cash provided by financing activities        1,232,933       1,033,908
Exchange rate effect on cash                        (6,337 )         2,185
Net cash outflow                            $       (1,153 )   $  (118,672 )




                                      20




Cash used in Operating Activities





For the nine months ended September 30, 2021, net cash used in operating
activities was $764,741, which consisted primarily of net loss of $657,863,
which was adjusted by depreciation and amortization of $40,899. The Company had
an increase of $370,068 in account payables and accrued payables in which it was
due to the Company purchased more raw materials and pay off the bills in longer
terms, an increase of $10,798 in accounts receivable which was due to longer
payment terms were offered to loyal customers , an increase of $190,971 in
prepayments to the suppliers for procurement of raw materials and deposit for
the building materials and equipment, and an increase of $306,913 in inventories
and an increase in other receivable of $12,693 in which it was due to an
increase in the borrowing from our employees.



For the nine months ended September 30, 2020, net cash used in operating
activities was $818,517, which consisted primarily of net loss of $678,194,
which was adjusted by depreciation and amortization of $29,435, bad debt
expenses of $185,323, loss from disposal of investment of $28,151 and conversion
of convertible bond of $14,006. The Company had a decrease of $13,648 in account
payables and accrued payables which was due to the Company purchased raw
materials and pay off the bills in shorter terms, an increase of $17,573 in
accounts receivable which was due to longer payment terms were offered to loyal
customers, an increase of $308,804 in prepayments to the suppliers for
procurement of raw materials and deposit for the building materials and
equipment, which were offset by a decrease of $8,917 in inventories and an
increase in other receivable of $62,582 which was due to an increase in the
borrowing from our employees, an increase of $24,464 in advances from customers
which was due to the Company received more purchasing orders from more
customers.



Cash used in Investing Activities





Net cash used in investing activities was $463,008 for the nine months ended
September 30, 2021. The activities consisted of our investments of $461,942 in
purchasing plant and equipment and an adjustment of $1,066 of intangible assets
due to currency exchange effect.



Net cash used in investing activities was $336,248 for the nine months ended
September 30, 2020. The activities consisted of our investments of $336,248 in
purchasing plant and equipment and construction in progress.





Cash Provided by Financing Activities

Net cash provided by financing activities was $1,232,933 for the nine months ended September 30, 2021. During this period, cash provided by financing activities mainly included proceeds from related parties of $800,126 and proceeds from long-term loan of $432,807 for operating expenses.





Net cash provided by financing activities was $1,033,908 for the nine months
ended September 30, 2020. During this period, cash provided by financing
activities mainly included proceeds from related parties of $833,562, proceeds
from issuance of common stocks of $186,048 and long-term loan of $14,298 for
operating expenses.



                                      21




Off-balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to its shares and classified as
shareholder's equity or that are not reflected in its consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. We do not have any variable interest in
any unconsolidated entity that provides financing, liquidity, market risk or
credit support to us or that engages in leasing, hedging or research and
development services with us.

© Edgar Online, source Glimpses